Elizabeth M Kang
National Institute of Allergy and Infectious Diseases (NIAID)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
NIH RePORTER
Trial papers
10
PubMed author-name match
Trials
Studies that name Elizabeth M Kang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:10 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07113743 · Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · enrolling by invitation · Chronic Granulomatous Disease (CGD) · principal investigator
- Ph1/Ph2NCT06253507 · pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)National Institute of Allergy and Infectious Diseases (NIAID) · enrolling by invitation · p47, Autosomal Recessive, Chronic Granulomatous Disease · principal investigator
- Early Ph1NCT05600907 · Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)National Institute of Allergy and Infectious Diseases (NIAID) · active not recruiting · Chronic Granulomatous Disease, CGD · principal investigator
- Ph1/Ph2NCT05463133 · Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) AntagonistsNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Chronic Granulomatous Disease · principal investigator
- Ph1/Ph2NCT04370795 · Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and SirolimusNational Institute of Allergy and Infectious Diseases (NIAID) · withdrawn · Severe Combined Immune Deficiency (SCID) · principal investigator
- Early Ph1NCT03910452 · Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant CyclophosphamideNational Institute of Allergy and Infectious Diseases (NIAID) · active not recruiting · Chronic Granulomatous Disease · principal investigator
- Ph1/Ph2NCT02629120 · High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · active not recruiting · Chronic Granulomatous Disease Transplant · principal investigator
- Ph1/Ph2NCT02282904 · Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant CyclophosphamideNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Chronic Granulomatous Disease · principal investigator
- N/ANCT02116764 · Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995National Institute of Allergy and Infectious Diseases (NIAID) · completed · Chronic Granulomatous Disease · principal investigator
- Ph1NCT01851460 · Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · withdrawn · Chronic Granulomatous Diseases (CGD) and Liver Lesions · principal investigator
- N/ANCT01123499 · Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal VolunteersNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Normal Physiology · principal investigator
- Early Ph1NCT00426517 · Donor Stem Cell Transplantation for Congenital ImmunodeficienciesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Inherited Immune Deficiencies · principal investigator
- Early Ph1NCT00394316 · Gene Therapy for Chronic Granulomatous DiseaseNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Chronic Granulomatous Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficienciesZIAAI000989 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2009 to 2025 · $542,130 awarded in 2025Same name and institution; not confirmed by an ID
- Gene Therapy Clinical Trials for Chronic Granulomatous DiseaseZIAAI000991 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2009 to 2019 · $361,831 awarded in 2019Same name and institution; not confirmed by an ID
- Clinical Trials of Allogeneic Transplantation for Inherited Immune DeficienciesZ01AI000989 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2007 to 2008 · $420,327 awarded in 2008Same name and institution; not confirmed by an ID
- Gene Therapy Clinical Trials for Chronic Granulomatous DiseaseZ01AI000991 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2007 to 2008 · $193,731 awarded in 2008Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:10 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.N Engl J Med · 2009354 citationsRCR 8.7
- 208 citationsRCR 8.7
- 129 citationsRCR 2.7
- 59 citationsRCR 1.5
- Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.N Engl J Med · 202627 citationsRCR 5.5
- 21 citationsRCR 1.2
- Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant · 201916 citationsRCR 0.7
- A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer.Lung Cancer · 201012 citationsRCR 0.3
- 6 citationsRCR 0.2
- A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.Int J Colorectal Dis · 20093 citationsRCR 0.1